Relay for Jack: Local Communities come together in support of National DIPG Awareness Week

For immediate release Relay for Jack: Local Communities come together in support of National DIPG Awareness Week May 24, 2016, Santa Clarita, CA—HRes586 was introduced to the House of Representatives Energy and Commerce Committee on January 13, 2016, by Congressman Steve Knight (R-CA-25) the day after the Moonshot Initiative was…

Continue reading

CCTR Presents Kathy Riley and We Can Pediatric Brain Tumor Network

Kathy Riley talks to CCTR about We Can Pediatric Brain Tumor Network, which began 20 years ago with the support and camaraderie between mothers of pediatric brain tumor patients.  The support and healing which came from their sharing was so helpful that they wanted to share it with others.  The…

Continue reading

ABC2: Funding Creativity in Brain Cancer Research

Max Wallace, President and CEO of ABC2–Accelerate Brain Cancer Cure, talks about founder and venture capitalist Dan Case who had been afflicted with, and ultimately died of brain cancer. ABC2 has for a model Dan’s genius for taking risks fearlessly and applying the venture approach to brain cancer research and…

Continue reading

Letter to President Obama

To President Barack Obama:                                                                                       Thursday May 5, 2016 I had the pleasure of meeting with Fae Jencks in the Office of Science and Technology this last Tuesday regarding an Awareness Resolution currently in the House of Representatives, HRes586, designating the 4th week of May to be National DIPG Awareness Week. …

Continue reading

What if?

Childhood Cancer Advocacy 101 What if it were your child?  God help you…you’d discover very quickly that the medical research system doesn’t consider your child’s life investment-worthy, that no therapies have been developed for this disease for decades, and that urgency of need and potential years of life lost are…

Continue reading

Dr. Charles Keller, Scientific Director of cc-TDI, speaks in Los Angeles 5/12/2016

(Taken from cc-TDI.org)  Dr. Keller’s research focuses on the development of more effective, less toxic therapies for childhood cancers. His special interest is advanced disease that has spread beyond the initial location of the cancer. Charles co-chairs the brain tumor developmental therapeutics committee (CNS-DVL) of the Children’s Oncology Group and is…

Continue reading